225 related articles for article (PubMed ID: 19270713)
1. CD98hc facilitates B cell proliferation and adaptive humoral immunity.
Cantor J; Browne CD; Ruppert R; Féral CC; Fässler R; Rickert RC; Ginsberg MH
Nat Immunol; 2009 Apr; 10(4):412-9. PubMed ID: 19270713
[TBL] [Abstract][Full Text] [Related]
2. Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2).
Fogelstrand P; Féral CC; Zargham R; Ginsberg MH
J Exp Med; 2009 Oct; 206(11):2397-406. PubMed ID: 19841087
[TBL] [Abstract][Full Text] [Related]
3. Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability.
de la Ballina LR; Cano-Crespo S; González-Muñoz E; Bial S; Estrach S; Cailleteau L; Tissot F; Daniel H; Zorzano A; Ginsberg MH; Palacín M; Féral CC
J Biol Chem; 2016 Apr; 291(18):9700-11. PubMed ID: 26945935
[TBL] [Abstract][Full Text] [Related]
4. CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior.
Poettler M; Unseld M; Braemswig K; Haitel A; Zielinski CC; Prager GW
Mol Cancer; 2013 Dec; 12():169. PubMed ID: 24359579
[TBL] [Abstract][Full Text] [Related]
5. The membrane-spanning domain of CD98 heavy chain promotes alpha(v)beta3 integrin signals in human extravillous trophoblasts.
Kabir-Salmani M; Fukuda MN; Kanai-Azuma M; Ahmed N; Shiokawa S; Akimoto Y; Sakai K; Nagamori S; Kanai Y; Sugihara K; Iwashita M
Mol Endocrinol; 2008 Mar; 22(3):707-15. PubMed ID: 18032696
[TBL] [Abstract][Full Text] [Related]
6. CD98 increases renal epithelial cell proliferation by activating MAPKs.
Bulus N; Feral C; Pozzi A; Zent R
PLoS One; 2012; 7(6):e40026. PubMed ID: 22768207
[TBL] [Abstract][Full Text] [Related]
7. CD98hc (SLC3A2) mediates integrin signaling.
Feral CC; Nishiya N; Fenczik CA; Stuhlmann H; Slepak M; Ginsberg MH
Proc Natl Acad Sci U S A; 2005 Jan; 102(2):355-60. PubMed ID: 15625115
[TBL] [Abstract][Full Text] [Related]
8. CD98 Heavy Chain Is a Potent Positive Regulator of CD4+ T Cell Proliferation and Interferon-γ Production In Vivo.
Kurihara T; Arimochi H; Bhuyan ZA; Ishifune C; Tsumura H; Ito M; Ito Y; Kitamura A; Maekawa Y; Yasutomo K
PLoS One; 2015; 10(10):e0139692. PubMed ID: 26444422
[TBL] [Abstract][Full Text] [Related]
9. CD98hc (SLC3A2) regulation of skin homeostasis wanes with age.
Boulter E; Estrach S; Errante A; Pons C; Cailleteau L; Tissot F; Meneguzzi G; Féral CC
J Exp Med; 2013 Jan; 210(1):173-90. PubMed ID: 23296466
[TBL] [Abstract][Full Text] [Related]
10. CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction.
Estrach S; Lee SA; Boulter E; Pisano S; Errante A; Tissot FS; Cailleteau L; Pons C; Ginsberg MH; Féral CC
Cancer Res; 2014 Dec; 74(23):6878-89. PubMed ID: 25267066
[TBL] [Abstract][Full Text] [Related]
11. Distinct domains of CD98hc regulate integrins and amino acid transport.
Fenczik CA; Zent R; Dellos M; Calderwood DA; Satriano J; Kelly C; Ginsberg MH
J Biol Chem; 2001 Mar; 276(12):8746-52. PubMed ID: 11121428
[TBL] [Abstract][Full Text] [Related]
12. CD98hc (SLC3A2) interaction with the integrin beta subunit cytoplasmic domain mediates adhesive signaling.
Prager GW; Féral CC; Kim C; Han J; Ginsberg MH
J Biol Chem; 2007 Aug; 282(33):24477-84. PubMed ID: 17597067
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation-related CD147-CD98 complex.
Xu D; Hemler ME
Mol Cell Proteomics; 2005 Aug; 4(8):1061-71. PubMed ID: 15901826
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-dependent regulation of T lymphocyte activation through CD98.
Diaz LA; Friedman AW; He X; Kuick RD; Hanash SM; Fox DA
Int Immunol; 1997 Sep; 9(9):1221-31. PubMed ID: 9310825
[TBL] [Abstract][Full Text] [Related]
15. Possible activation of murine T lymphocyte through CD98 is independent of interleukin 2/interleukin 2 receptor system.
Komada H; Imai A; Hattori E; Ito M; Tsumura H; Onoda T; Kuramochi M; Tani M; Yamamoto K; Yamane M; Kawano M; Nishio M; Yuasa K; O'Brien M; Yamamoto H; Uematsu J; Tsurudome M; Ito Y
Biomed Res; 2006 Apr; 27(2):61-7. PubMed ID: 16707844
[TBL] [Abstract][Full Text] [Related]
16. Conditional deletion of CD98hc inhibits osteoclast development.
Tsumura H; Ito M; Takami M; Arai M; Li XK; Hamatani T; Igarashi A; Takada S; Miyado K; Umezawa A; Ito Y
Biochem Biophys Rep; 2016 Mar; 5():203-210. PubMed ID: 28955825
[TBL] [Abstract][Full Text] [Related]
17. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation.
Henderson NC; Collis EA; Mackinnon AC; Simpson KJ; Haslett C; Zent R; Ginsberg M; Sethi T
J Biol Chem; 2004 Dec; 279(52):54731-41. PubMed ID: 15485886
[TBL] [Abstract][Full Text] [Related]
18. Deletion of CD98 heavy chain in T cells results in cardiac allograft acceptance by increasing regulatory T cells.
Liu Z; Hou J; Chen J; Tsumura H; Ito M; Ito Y; Hu X; Li XK
Transplantation; 2012 Jun; 93(11):1116-24. PubMed ID: 22588539
[TBL] [Abstract][Full Text] [Related]
19. CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Cantor JM
J Neuroimmunol; 2014 Sep; 274(1-2):230-3. PubMed ID: 25002078
[TBL] [Abstract][Full Text] [Related]
20. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
